Cellular screening assays using fluorescence microscopy.

The recent development of automated fluorescence imaging systems has enabled fluorescence microscopy to be used for the purposes of compound screening. This information-rich technique has found various applications, including screening for the effect of kinase inhibitors on the cytoskeleton, agonist-stimulated receptor internalization, and protein phosphorylation and acetylation. The discovery of novel fluorescent proteins and new fluorescent dyes will find many applications in multichannel fluorescence imaging assays.

[1]  M. Röllinghoff,et al.  A stable marker for specific T-cells: a TCR alpha/green fluorescent protein (GFP) fusionprotein reconstitutes a functionally active TCR complex. , 2000, JIM - Journal of Immunological Methods.

[2]  A. C. Chinault,et al.  Immunofluorescent studies of human chromosomes with antibodies against phosphorylated H1 histone , 2000, Chromosoma.

[3]  G. Milligan Exploring the dynamics of regulation of G protein‐coupled receptors using green fluorescent protein , 1999, British journal of pharmacology.

[4]  Edward M. Goldberg,et al.  Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology , 1999, Journal of biomolecular screening.

[5]  G. Milligan,et al.  Molecular manipulation of G-protein-coupled receptors: a new avenue into drug discovery. , 2000, Current medicinal chemistry.

[6]  Y. T. Chen,et al.  Cell-based, high-content screen for receptor internalization, recycling and intracellular trafficking. , 2000, BioTechniques.

[7]  G. Mcmahon,et al.  Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. , 1999, Journal of medicinal chemistry.

[8]  K A Giuliano,et al.  Fluorescent-protein biosensors: new tools for drug discovery. , 1998, Trends in biotechnology.

[9]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[10]  J. Hermes,et al.  Detection of p56lck Kinase Activity Using Scintillation Proximity Assay in 384-Well Format and Imaging Proximity Assay in 384- and 1536-Well Format , 2000, Journal of biomolecular screening.

[11]  G. Mcmahon,et al.  Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. , 1998, Journal of medicinal chemistry.

[12]  T R Sharif,et al.  A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells. , 1999, International journal of oncology.

[13]  S. Archer,et al.  Histone acetylation and cancer. , 1999, Current opinion in genetics & development.

[14]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[15]  P. Marchisio,et al.  Ultrastructure and gold-immunolabelling of cell-substratum adhesions (podosomes) in RSV-transformed BHK cells. , 1989, Journal of cell science.

[16]  Kevin R. Oldenburg,et al.  Miniaturization of a Mammalian Cell-Based Assay: Luciferase Reporter Gene Readout in a 3 Microliter 1536-Well Plate , 1999, Journal of biomolecular screening.

[17]  L. Mattheakis,et al.  Assay technologies for screening ion channel targets. , 2001, Current opinion in drug discovery & development.

[18]  G. Plowman,et al.  The discovery and validation of new drug targets in cancer. , 1998, Current opinion in biotechnology.

[19]  R. Boltz,et al.  Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. , 1998, The Journal of biological chemistry.

[20]  Shelagh Wilson,et al.  Visualization of Agonist-induced Association and Trafficking of Green Fluorescent Protein-tagged Forms of Both β-Arrestin-1 and the Thyrotropin-releasing Hormone Receptor-1* , 1999, The Journal of Biological Chemistry.

[21]  D. Grandy,et al.  Binding and internalization of fluorescent opioid peptide conjugates in living cells. , 2000, Molecular pharmacology.

[22]  K K Baldridge,et al.  The structure of the chromophore within DsRed, a red fluorescent protein from coral. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Ranganathan,et al.  The structural basis for red fluorescence in the tetrameric GFP homolog DsRed , 2000, Nature Structural Biology.

[24]  G. Milligan,et al.  Insights into ligand pharmacology using receptor-G-protein fusion proteins. , 2000, Trends in pharmacological sciences.

[25]  C. Allis,et al.  Increased Ser-10 Phosphorylation of Histone H3 in Mitogen-stimulated and Oncogene-transformed Mouse Fibroblasts* , 1999, The Journal of Biological Chemistry.

[26]  R. Stocco,et al.  A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture. , 2000, Analytical biochemistry.

[27]  B. Neagle,et al.  FLIPR: A New Instrument for Accurate, High Throughput Optical Screening , 1996 .

[28]  G. Milligan,et al.  Ligand regulation of green fluorescent protein‐tagged forms of the human β1‐ and β2‐adrenoceptors; comparisons with the unmodified receptors , 2000 .

[29]  R. Haugland,et al.  Alexa Dyes, a Series of New Fluorescent Dyes that Yield Exceptionally Bright, Photostable Conjugates , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  S T Hess,et al.  Molecular spectroscopy and dynamics of intrinsically fluorescent proteins: coral red (dsRed) and yellow (Citrine). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Bazett-Jones,et al.  Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation. , 1998, Molecular biology of the cell.

[32]  P. Lamb,et al.  Pharmaceutical intervention in the JAK/STAT signaling pathway , 2000, Oncogene.

[33]  S. Wilson,et al.  Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein. , 2001, Molecular pharmacology.

[34]  E. Schenborn,et al.  Reporter gene vectors and assays , 1999, Molecular biotechnology.

[35]  J. Northrop,et al.  Expression of cre recombinase as a reporter of signal transduction in mammalian cells. , 1999, Chemistry & biology.

[36]  S. Lukyanov,et al.  Fluorescent proteins from nonbioluminescent Anthozoa species , 1999, Nature Biotechnology.

[37]  Nasir Ms,et al.  Fluorescence polarization: an analytical tool for immunoassay and drug discovery. , 1999, Combinatorial chemistry & high throughput screening.

[38]  R. Hertzberg,et al.  High-throughput screening: new technology for the 21st century. , 2000, Current opinion in chemical biology.

[39]  S. Rees,et al.  Visualizing differences in ligand regulation of wild-type and constitutively active mutant beta(2)-adrenoceptor-green fluorescent protein fusion proteins. , 1999, Molecular pharmacology.

[40]  P. Fernandes,et al.  Technological advances in high-throughput screening. , 1998, Current opinion in chemical biology.

[41]  S. Haggarty,et al.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.

[42]  D L Taylor,et al.  Real-time molecular and cellular analysis: the new frontier of drug discovery. , 2001, Current opinion in biotechnology.

[43]  S A Sundberg,et al.  High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.

[44]  J. Novotný,et al.  Visualization of distinct patterns of subcellular redistribution of the thyrotropin-releasing hormone receptor-1 and gqalpha /G11alpha induced by agonist stimulation. , 1999, The Biochemical journal.